Full Text View
Tabular View
No Study Results Posted
Related Studies
Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
This study has been terminated.
( All enrollment, treatment, follow-up & data analysis completed )
Study NCT00667901   Information provided by University of Medicine and Dentistry New Jersey

First Received on April 25, 2008.   Last Updated on December 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melanoma (Skin)
Additional conditions recognized in this trial
Melanoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Interventions listed in this trial
riluzole
protein expression analysis
western blotting
laboratory biomarker analysis
pharmacological study
neoadjuvant therapy
therapeutic conventional surgery
More general drug interventions related to this trial
Anticonvulsants
Central Nervous System Agents
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
University of Medicine and Dentistry New Jersey
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services